Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
详细信息    查看全文
文摘
Masih Daneshvari Hospital, Tehran, Iran, 2000–2002.

Objective:

To evaluate the effectiveness of multiple drug-resistant tuberculosis (MDR-TB) treatment for the first time in Iran.

Design:

All cases of MDR-TB with complete follow-up data were recruited and results of their treatments were evaluated.

Results:

MDR-TB treatment was initiated with 5.23 drugs, on average. Isoniazid, amikacin, and ofloxacin were present in the drug regimen of all patients. Average duration of the treatment was 18.5 months (range, 7–36). Over 76 % of the patients responded to the treatment (negative smear and culture). Cure and probable cure were documented in seven (41.2 % ) and four (23.5 % ) of the patients, respectively. No failure in the treatment occurred when cycloserine was present in the treatment regimen.

Conclusion:

A majority of the MDR-TB patients in Iran can be cured with the use of appropriate treatment regimens. An even greater success could be achieved by providing more second-line drugs.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700